Open AccessEffect of tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospective cohort study
Author(s) -
Mehtap Pehlivanlar Küçük,
Ahmet Küçük,
Ayşegül Pehlivanlar,
Emine Sevil Ayaydin Mürtezaoğlu,
Kadir Çoban,
Gamze Kılıç,
Olcay Ayçiçek,
Funda Öztuna,
Yılmaz Bülbül,
Tevfik Özlü
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2106-42
Subject(s) - medicine , tocilizumab , retrospective cohort study , pneumonia , covid-19 , intensive care , cohort , cohort study , intensive care medicine , emergency medicine , rheumatoid arthritis , disease , infectious disease (medical specialty)
In this study, the efficacy of an IL-6 antagonist, Tocilizumab, administered in the early period was studied in intensive care patients with COVID-19 pneumonia followed by hypoxic and systemic inflammation not receiving mechanical ventilation support.